Sirnaomics Initiates Phase 2 Study Using STP705 for Keloid Scar Prevention ...Middle East

PR Newswire - News
Sirnaomics Initiates Phase 2 Study Using STP705 for Keloid Scar Prevention
GAITHERSBURG, Md. and SUZHOU BIOBAY, China, April 18, 2021 /PRNewswire/ -- Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced the initiation of a Phase 2 study of the company's...

Hence then, the article about sirnaomics initiates phase 2 study using stp705 for keloid scar prevention was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sirnaomics Initiates Phase 2 Study Using STP705 for Keloid Scar Prevention )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
Aljazeera - before 11 hour & 41 minute